Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Kiropraktor Skanderborg ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.0% 9.2% 7.7% 7.5% 7.6% 6.3% 9.3% 9.3%   Credit score (0-100)   40 27 30 32 31 37 27 27   Credit rating   BBB BB BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,219 2,610 2,726 2,318 2,127 2,165 0.0 0.0   EBITDA   548 728 419 374 367 457 0.0 0.0   EBIT   206 409 54.6 39.2 32.4 84.6 0.0 0.0   Pre-tax profit (PTP)   156.0 377.2 28.3 -15.6 -66.6 -1.4 0.0 0.0   Net earnings   118.5 298.9 15.5 -15.0 -52.3 -1.6 0.0 0.0   Pre-tax profit without non-rec. items   156 377 28.3 -15.6 -66.6 -1.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   118 180 1,204 1,365 1,191 1,383 0.0 0.0   Shareholders equity total   168 447 313 298 246 244 194 194   Interest-bearing liabilities   1,503 870 1,826 1,995 1,763 1,833 445 445   Balance sheet total (assets)   2,047 1,939 2,548 2,504 2,251 2,225 639 639   Net Debt   1,492 861 1,824 1,993 1,756 1,830 445 445     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,219 2,610 2,726 2,318 2,127 2,165 0.0 0.0   Gross profit growth   0.0% 17.6% 4.4% -15.0% -8.2% 1.8% -100.0% 0.0%   Employees   3 3 5 4 4 4 0 0   Employee growth %   0.0% 0.0% 66.7% -20.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,047 1,939 2,548 2,504 2,251 2,225 639 639   Balance sheet change%   0.0% -5.3% 31.4% -1.7% -10.1% -1.2% -71.3% 0.0%   Added value   548.0 727.7 418.7 373.9 367.1 457.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,466 -542 374 -333 -669 -340 -1,383 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.3% 15.7% 2.0% 1.7% 1.5% 3.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.1% 20.5% 2.5% 1.6% 1.4% 3.8% 0.0% 0.0%   ROI %   12.4% 27.4% 3.2% 1.8% 1.5% 4.1% 0.0% 0.0%   ROE %   70.3% 97.1% 4.1% -4.9% -19.3% -0.7% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   8.2% 23.1% 12.3% 11.9% 10.9% 11.0% 30.3% 30.3%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   272.3% 118.3% 435.5% 532.9% 478.2% 400.3% 0.0% 0.0%   Gearing %   891.9% 194.5% 583.5% 669.6% 717.9% 751.3% 229.5% 229.5%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.7% 2.7% 2.0% 2.9% 5.3% 4.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0   Cash and cash equivalent   10.1 9.3 2.0 2.1 7.2 3.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,639.5 -1,137.3 -1,997.2 -2,014.5 -1,744.2 -1,778.4 -222.6 -222.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   183 243 84 93 92 114 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   183 243 84 93 92 114 0 0   EBIT / employee   69 136 11 10 8 21 0 0   Net earnings / employee   39 100 3 -4 -13 -0 0 0